C Pannecouque Selected Research

C Pannecouque Research Topics

6	Acquired Immunodeficiency Syndrome (AIDS) 01/2005 - 01/2000
3	HIV Infections (HIV Infection) 01/2018 - 08/2004
2	Herpes Simplex 05/2012 - 11/2010
2	Infections 01/2005 - 06/2000
2	Neoplasms (Cancer) 10/2004 - 10/2001
1	Vesicular Stomatitis 09/2010
1	Papilloma (Papillomatosis) 01/2005
1	Poxviridae Infections 01/2005
1	Vaccinia 01/2005
1	Cowpox 01/2005
1	Cytomegalovirus Retinitis 01/2005
1	Chronic Hepatitis B 01/2005
1	Tuberculosis (Tuberculoses) 10/2001
1	Human Influenza (Influenza) 02/2001
1	Glucose Intolerance 01/2001
1	Nephrolithiasis 01/2001

5	Antiviral Agents (Antivirals)IBA 05/2012 - 01/2000
3	NucleosidesIBA 01/2005 - 10/2001
2	ProdrugsIBA 09/2010 - 03/2001
2	Tenofovir (Viread)FDA Link 01/2005 - 10/2004
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	BuffersIBA 01/2018
1	pyridineIBA 05/2012
1	QuinoxalinesIBA 05/2012
1	Zidovudine (Retrovir)FDA LinkGeneric 05/2012
1	AcidsIBA 11/2010
1	EstersIBA 09/2010
1	CytosineIBA 01/2005
1	Cidofovir (Vistide)FDA Link 01/2005
1	9- (3- hydroxy- 2- phosphonomethoxypropyl)- 2,6- diaminopurineIBA 01/2005
1	alkoxyl radicalIBA 01/2005
1	Organophosphonates (Phosphonates)IBA 01/2005
1	9- (S)- (3- hydroxy- 2- (phosphonomethoxy)propyl)adenineIBA 01/2005
1	Adenine FDA LinkGeneric 01/2005
1	adefovir dipivoxil (Hepsera)FDA Link 01/2005
1	6- phosphonylmethoxyethoxy- 2,4- diaminopyrimidineIBA 10/2004
1	adefovirIBA 10/2004
1	Amantadine (Aman)FDA LinkGeneric 02/2001
1	Rimantadine FDA LinkGeneric 02/2001
1	Viral RNAIBA 01/2001
1	Anti-HIV Agents (AIDS Drugs)IBA 06/2000

3	Therapeutics 01/2001 - 01/2000
1	Highly Active Antiretroviral Therapy (HAART) 08/2004